Notably, Kaplan–Meier analysis revealed that neither p62 mutations nor CNV were associated with OS among TCGA cancer patient samples (Fig. 1C–E), suggesting that genomic alterations have no significant prognostic value across cancers (Fig. 1C–E). Here, SQSTM1 is linked to cancer.